|
|
Antimicrobial Stewardship
Drug Shortages
Minor: metronidazole intravenous
Critical: levofloxacin intravenous
Unavailable:neomycin/polymyxin
Antimicrobial Stewardship Schedule
Antimicrobial Stewardship Updates
 |
The health system has developed treatment guidance for patients diagnosed with SARS-CoV-2 (COVID-19) infection. To view these guidelines, click this link. We encourage you to check these guidelines frequently, as they may rapidly change based on new information. |
 |
To get the ILÚM app, search and download on iTunes or GoogleTM Play. The app can be used to request antibiotic approval, perform predictive analytics, search guidelines, and see UPHS antibiograms. The same functionality is also available on the ILÚM website. |
Antimicrobial Stewardship Policy and Mission
The prevalence of antimicrobial resistance is increasing at an alarming rate, placing critical importance on the preservation of available antimicrobial agents. Antimicrobial stewardship is a practice aimed at monitoring and guiding antimicrobial use in healthcare settings using evidence-based practices. It is known that approximately 50% of inpatient antimicrobial use is inappropriate, and there is a clear association between use of antimicrobials and development of resistance. Numerous studies and national guidelines have supported stewardship as an integral strategy to reduce emergence of antimicrobial resistance, improve patient outcomes, and decrease healthcare costs.
The goals of the antimicrobial stewardship team are to:
- Provide support to healthcare workers.
- Decrease inappropriate antimicrobial use.
- Optimize selection, dose, and duration of antimicrobial therapy.
- Streamline costs associated with antimicrobial use.
- Decrease spread and emergence of antimicrobial resistance.
- Improve patient outcomes.
Hospital antimicrobial stewardship policies can be found at the following links (available only on Penn Medicine networks):
Email Webmaster
|
